Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Attention Training

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT01518738
First received: January 13, 2012
Last updated: June 3, 2014
Last verified: June 2014
  Purpose

The purpose of this study is to understand whether attention training is effective in moderating mind wandering.


Condition Intervention
Attention
Behavioral: breath attention training
Behavioral: working memory attention training

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Attention Training

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • change in mind wandering frequency after intervention [ Time Frame: before intervention and up to 100 weeks later ] [ Designated as safety issue: No ]
    mind wandering will be assessed with self-report to intermittent queries such as "just now, was your attention on the present task or unrelated concerns?" Frequency of endorsement will serve as a measure of frequency of mind wandering (ranging in units from 0 - 100% of the time).


Enrollment: 94
Study Start Date: February 2012
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: breath attention training Behavioral: breath attention training
4 week training
Active Comparator: working memory attention training Behavioral: working memory attention training
4 week training
No Intervention: no training

Detailed Description:

Our subjective worlds are built from those things in our internal and external environments that capture our attention. Environments can be ambiguous with respect to which objects are most important for our attention, and the characteristics of stimuli that allow them to dominate attention are thus of great interest. Self-relevant objects, such as internally generated experience (e.g. thought), may receive substantial attention, but research on this dimension has been hampered by the difficulty of measuring such objects experimentally. The proposed study seeks to make headway in this area using several behavioral (accuracy, response time, response pattern) measures, with the hypothesis that internally generated experience will vie for attention in a way reflected by behavior. Such research will extend previous work the investigators' lab has done studying stimulus parameters that influence attention, and as a whole may present a more complete picture of how objects and attention interact to shape our worlds.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Exclusion Criteria:

  • Non-English speakers

Inclusion Criteria:

  • Must be able to use a computer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01518738

Locations
United States, Wisconsin
University of Wisconsin Brogden Psychology Building
Madison, Wisconsin, United States, 53706
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Richard Davidson, PhD University Wisconsin Madison
  More Information

No publications provided

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT01518738     History of Changes
Other Study ID Numbers: SE-2011-0123
Study First Received: January 13, 2012
Last Updated: June 3, 2014
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 27, 2014